Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Pharmacogenomics ; 21(1): 7-21, 2020 01.
Article in English | MEDLINE | ID: mdl-31849280

ABSTRACT

Aim: The influence of variants in pharmacokinetics-related genes on long-term exposure to tacrolimus (TAC)-based therapy and clinical outcomes was investigated. Patients & methods: Brazilian kidney recipients were treated with TAC combined with everolimus (n = 178) or mycophenolate sodium (n = 97). The variants in CYP2C8, CYP2J2, CYP3A4, CYP3A5, POR, ABCB1, ABCC2, ABCG2, SLCO1B1 and SLCO2B1 were analyzed. Main results:CYP3A5*3/*3 genotype influenced increase in TAC concentration from week 1 to month 6 post-transplantation (p < 0.05). The living donor and CYP2C8*3 variant were associated with reduced risk for delayed graft function (OR = 0.07; 95% CI = 0.03-0.18 and OR = 0.45; 95% CI = 0.20-0.99, respectively, p < 0.05). Conclusion: The CYP3A5*3 variant is associated with increased early exposure to TAC. Living donor and CYP2C8*3 variant seem to be protective factors for delayed graft function in kidney recipients.


Subject(s)
Cytochrome P-450 CYP2C8/genetics , Cytochrome P-450 CYP3A/genetics , Immunosuppressive Agents/adverse effects , Kidney Transplantation/adverse effects , Tacrolimus/adverse effects , Adult , Brazil/epidemiology , Female , Genotype , Humans , Immunosuppression Therapy/methods , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/immunology , Kidney/drug effects , Kidney/pathology , Male , Middle Aged , Multidrug Resistance-Associated Protein 2 , Polymorphism, Single Nucleotide/genetics , Tacrolimus/administration & dosage , Tacrolimus/immunology , Treatment Outcome
2.
Pediatr Diabetes ; 13(2): 147-54, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21848584

ABSTRACT

OBJECTIVE: To study the activation of an inflammatory cascade through leukocyte mRNA expression of TLR2, TLR4, MyD88, and pro-inflammatory cytokines in individuals with childhood onset type 1 diabetes. DESIGN AND METHODS: Seventy-six type 1 diabetic patients and 100 normoglycemic subjects (NG) 6 to 20 years old were recruited. Type 1 diabetic patients (DM1) were considered to have good (DM1G) or poor (DM1P) glycemic control according to the values of glycated hemoglobin. TLR2, TLR4, MyD88, interleukin -1ß (IL-1ß), IL-6, and tumor necrosis factor alpha (TNF-α) mRNA expressions were measured in peripheral blood leukocytes (PBL) by real-time polymerase chain reaction (PCR). Urea, creatinine, albumin, and total protein serum levels were determined. Urinary albumin-to-creatinine ratio (ACR) was calculated. RESULTS: DM1 and DM1P patients showed higher glycated hemoglobin (10 and 11%, respectively) and serum glucose concentrations (208 and 226 mg/dL, respectively) compared to NG (Glycated hemoglobin: 7% and glucose: 76 mg/dL) (p < 0.05). PBL mRNA expressions of TLR2, MyD88, IL-1ß, IL-6, and TNF-α were higher in DM1 and TLR2, IL-1ß, and IL-6 expressions were higher in DMP1 compared to NG (p < 0.05). In DM1, serum albumin and total protein were lower, while serum urea and ACR were higher in comparison to NG (p < 0.05). However, these differences compared to NG were more pronounced in DM1P, which included nine individuals with microalbuminuria. CONCLUSIONS: Increased mRNA expression of TLR2, MyD88, and pro-inflammatory cytokines in leukocytes of patients with childhood onset type 1 diabetes indicates the development of a TLR2-mediated pro-inflammatory process, which may also be associated with an early inflammatory process in the kidney and the occurrence of microalbuminuria.


Subject(s)
Albuminuria/metabolism , Diabetes Mellitus, Type 1/metabolism , Diabetic Nephropathies/metabolism , Toll-Like Receptor 2/biosynthesis , Adolescent , Child , Creatinine/blood , Creatinine/urine , Cytokines/blood , Diabetes Mellitus, Type 1/blood , Female , Humans , Leukocytes/metabolism , Male , Myeloid Differentiation Factor 88/biosynthesis , Risk , Serum Albumin/metabolism , Toll-Like Receptor 4/biosynthesis , Urea/blood , Urea/urine , Young Adult
3.
Clin Chim Acta ; 377(1-2): 154-162, Feb 2007. graf
Article in English | Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1062051

ABSTRACT

Background: We investigated the relationship between NOS3, FGB and PAI-1 polymorphisms and endothelial dysfunction and risk factors for acute myocardial infarction (AMI) in young adults.Methods: Endothelial function was measured by response to flow mediated vasodilation (FMV) and induced by nitrate (FMN). Biochemical parameters were measured by standard enzymatic methods and plasma total nitrate was analyzed by the NOA™system. NOS3 (T-786C, G894T and intron 4A/B STR), FGB (C-148T and G-455A) and PAI-1 (4G/5G) polymorphisms were determined by PCR-RFLP.Results: Concentrations of total and LDL cholesterol, apo B, triglycerides, nitrate, PAI-1 and fibrinogen were higher and apo AI, HDL cholesterol and FMVwere lower in AMI patients than in controls ( pb0.001). PAI-1 ( pb0.001) but not nitrate was higher in AMI patients with low response toFMV. NOS3 T-786C and FGB C-148T polymorphisms were associated with AMI ( pb0.050). NOS3 T-786C was also related to hypertension ( p=0.049).NOS3 intron 4A/B STR was associated with increased concentrations of total cholesterol and apo B. NOS3-786TT/894GT haplotype was associated with increased FMV ( p=0.018) than the other haplotypes. Conclusions: Our data suggest NOS3 and FGB polymorphisms are associated with AMI. NOS3 is also related to hypertension, endothelialdysfunction and variation on serum cholesterol in young adults with AMI.


Subject(s)
Hypertension , Myocardial Infarction , Cholesterol, LDL , Polymorphism, Genetic , Vasodilation , Nitric Oxide Synthase
4.
São Paulo; s.n; 2000. 71 p. ilus, tab, graf.
Thesis in Portuguese | LILACS | ID: lil-276152

ABSTRACT

Estudamos a regulação de enzimas da via de metabolização da L-arginina (óxido nítrico sintase induzível, iNOS, ornitina descarboxilase, ODC, e ornitina aminotransferase, OAT) pelo hormônio de crescimento (GH) em células mesangiais e em córtex renal de camundongos bGH. Estes animais apresentam concentração sérica elevada de GH e desenvolvem glomerulosclerose (GS) progressiva. Há várias evidências da participação do GH no desenvolvimento de GS. Demonstrou-se também uma associação entre o acúmulo de matrix extracelular (MEC) nos glomérulos e a expressão aumentada de iNOS, OAT e ODC. Nós demonstramos, pela primeira vez, uma ligação entre o GH e a iNOS em células mesangiais, além de uma expressão aumentada desta enzima em córtex renal de camundongo bGH com GS severa...


Subject(s)
Gene Expression Regulation, Enzymologic , Growth Hormone , In Vitro Techniques , Nitric Oxide Synthase/genetics , Nitrites , Ornithine Decarboxylase , Ornithine-Oxo-Acid Transaminase , Culture Media , Mice, Transgenic , Polymerase Chain Reaction , Sclerosis
5.
Rev. bras. oftalmol ; 46(5): 5-13, out. 1987. ilus, tab
Article in Portuguese | LILACS | ID: lil-348077

ABSTRACT

Uma correlação entre retinopatia diabética e certo tipo de anormalidades de mão, em contratura é analisada sobre uma população de 81 pacientes diabéticos. A gravidade da retinopatia proliferativa e outras alterações microvasculares na presença das contraturas é ressaltada em seis casos com severa anomalia de mão, e 14 com alterações moderadas, onde a frequencia e gravidade da retinopatia foi superior à da população sem anormalidades (50 por cento e 30 por cento respectivamente); alto nível de correlação foi encontrado entre retinpatia diabética proliferativa e presença de alterações de mão. O autor conclui com base na casuístia apresentada e recentes dados da literatura, ser esta população de diabéticos de alto risco ao desenvolvimento de complicações microvasculares, principalmente retinopatia grave, sendo o exame das mãos, de fácil execução, importante subsídio à detecção e triagem dessa população de risco.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Hand Deformities, Acquired/etiology , Diabetic Retinopathy , Hand Deformities, Acquired , Diagnosis-Related Groups
SELECTION OF CITATIONS
SEARCH DETAIL
...